With lower costs of production, a much lower cost to consumers, no medical transfusions or surgery, an excellent safety profile and the ability to dial up the dosage in a safe and non harmful way without significant side effects such as those present with Leqembi, Xanamem represents a drug that could be viewed by the FDA as a cost effective drug with an exemplary safety profile. Xanamem can even be taken alongside your other medication according to an independent review of medical professionals earlier this year.
With the potential to shorten the onset of Alzeihmer's at a much greater rate than Leqembi, what could Actinogen's pipeline in a pill be worth?
DYOR
ACW Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)